Highlights

July 22, 2020

Real-world analysis of nivolumab dosing regimens show that duration of therapy and adverse effects are similar for doses every 2 or 4 weeks

The analysis was performed in an oncology setting of the American community Real-world results of adjuvant treatment of melanoma in an American community oncology setting were […]

July 22, 2020

Update of OpACIN and OpACIN-neo trials indicates benefit of neoadjuvant immunotherapy in patients with stage IIIB / IIIC melanoma

Update data on recurrence-free survival were evaluated in the OpACIN and OpACIN-neo trials, which were presented at AACR 2020 Update data on 36- and 18-month recurrence-free […]

July 20, 2020

Liquid biopsy data to detect METex14 changes and MET amplification in patients with advanced lung cancer are presented in the AACR

Liquid biopsy by NGS analysis has become a non-invasive alternative in the detection of somatic tumor changes in patients with changes in METex14 and amplification of […]

May 12, 2020

Highlights of AACR 2020

On the first day of the virtual event, four papers with clinical emphasis were selected, two about melanoma, one about breast cancer and the other one […]

May 11, 2020

News about early detection of cancer and DNAct are released at AACR 2020

One of the most convincing approaches to reduce cancer-specific morbimortality is early detection. One of the tests used for this is the liquid biopsy done in […]

May 4, 2020

Study analyzes efficacy and safety of pembrolizumab combined with GX-188E, a DNA vaccine, in patients with advanced cervical cancer

The results were presented in the “Clinical Plenary: Immunotherapy Clinical Trials 1” session of AACR 2020 During the AACR Annual Meeting 2020, in one of the […]